Logo image of CNNE

CANNAE HOLDINGS INC (CNNE) Stock Fundamental Analysis

NYSE:CNNE - US13765N1072 - Common Stock

18.7 USD
+0.03 (+0.16%)
Last: 8/29/2025, 8:14:01 PM
18.7 USD
0 (0%)
After Hours: 8/29/2025, 8:14:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CNNE. CNNE was compared to 101 industry peers in the Financial Services industry. While CNNE seems to be doing ok healthwise, there are quite some concerns on its profitability. CNNE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNNE had negative earnings in the past year.
In the past year CNNE has reported a negative cash flow from operations.
In the past 5 years CNNE reported 4 times negative net income.
CNNE had a negative operating cash flow in each of the past 5 years.
CNNE Yearly Net Income VS EBIT VS OCF VS FCFCNNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of -23.04%, CNNE is doing worse than 91.18% of the companies in the same industry.
The Return On Equity of CNNE (-29.79%) is worse than 88.24% of its industry peers.
Industry RankSector Rank
ROA -23.04%
ROE -29.79%
ROIC N/A
ROA(3y)-13.01%
ROA(5y)-1.54%
ROE(3y)-15.27%
ROE(5y)-1.43%
ROIC(3y)N/A
ROIC(5y)N/A
CNNE Yearly ROA, ROE, ROICCNNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

CNNE has a Gross Margin of 16.13%. This is in the lower half of the industry: CNNE underperforms 64.71% of its industry peers.
In the last couple of years the Gross Margin of CNNE has grown nicely.
CNNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.75%
GM growth 5Y3.28%
CNNE Yearly Profit, Operating, Gross MarginsCNNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

More info and screens

6

2. Health

2.1 Basic Checks

CNNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CNNE has been reduced compared to 1 year ago.
CNNE has less shares outstanding than it did 5 years ago.
CNNE has a worse debt/assets ratio than last year.
CNNE Yearly Shares OutstandingCNNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CNNE Yearly Total Debt VS Total AssetsCNNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CNNE has an Altman-Z score of 2.00. This is not the best score and indicates that CNNE is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CNNE (2.00) is better than 74.51% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that CNNE is not too dependend on debt financing.
CNNE has a better Debt to Equity ratio (0.04) than 82.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 2
ROIC/WACCN/A
WACC8.22%
CNNE Yearly LT Debt VS Equity VS FCFCNNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 2.78 indicates that CNNE has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.78, CNNE belongs to the best of the industry, outperforming 81.37% of the companies in the same industry.
A Quick Ratio of 2.78 indicates that CNNE has no problem at all paying its short term obligations.
CNNE's Quick ratio of 2.78 is amongst the best of the industry. CNNE outperforms 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 2.78
Quick Ratio 2.78
CNNE Yearly Current Assets VS Current LiabilitesCNNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

2

3. Growth

3.1 Past

CNNE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.03%.
The Revenue for CNNE has decreased by -11.07% in the past year. This is quite bad
Measured over the past years, CNNE shows a very negative growth in Revenue. The Revenue has been decreasing by -15.81% on average per year.
EPS 1Y (TTM)1.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.83%
Revenue 1Y (TTM)-11.07%
Revenue growth 3Y-15.21%
Revenue growth 5Y-15.81%
Sales Q2Q%-6.61%

3.2 Future

CNNE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.25% yearly.
The Revenue is expected to decrease by -3.75% on average over the next years.
EPS Next Y3.73%
EPS Next 2Y30.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.69%
Revenue Next 2Y-3.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNNE Yearly Revenue VS EstimatesCNNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CNNE Yearly EPS VS EstimatesCNNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5 10 15 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CNNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CNNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNNE Price Earnings VS Forward Price EarningsCNNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNNE Per share dataCNNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as CNNE's earnings are expected to grow with 30.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.25%
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

CNNE has a Yearly Dividend Yield of 2.73%.
Compared to an average industry Dividend Yield of 4.26, CNNE pays a bit more dividend than its industry peers.
CNNE's Dividend Yield is comparable with the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.73%

5.2 History

CNNE has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNNE Yearly Dividends per shareCNNE Yearly Dividends per shareYearly Dividends per share 2021 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of CNNE are negative and hence is the payout ratio. CNNE will probably not be able to sustain this dividend level.
DP-7.36%
EPS Next 2Y30.25%
EPS Next 3YN/A
CNNE Yearly Income VS Free CF VS DividendCNNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

More info and screens

CANNAE HOLDINGS INC

NYSE:CNNE (8/29/2025, 8:14:01 PM)

After market: 18.7 0 (0%)

18.7

+0.03 (+0.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners88.21%
Inst Owner Change-3.15%
Ins Owners10.31%
Ins Owner Change0.12%
Market Cap1.05B
Analysts85
Price Target22.44 (20%)
Short Float %3.93%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield 2.73%
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP-7.36%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-16 2025-09-16 (0.15)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-820.52%
Min EPS beat(2)-1301.07%
Max EPS beat(2)-339.96%
EPS beat(4)1
Avg EPS beat(4)-446.98%
Min EPS beat(4)-1301.07%
Max EPS beat(4)0.45%
EPS beat(8)1
Avg EPS beat(8)-537.2%
EPS beat(12)3
Avg EPS beat(12)-359.08%
EPS beat(16)3
Avg EPS beat(16)-2527.74%
Revenue beat(2)0
Avg Revenue beat(2)-2.83%
Min Revenue beat(2)-3.92%
Max Revenue beat(2)-1.74%
Revenue beat(4)2
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-3.92%
Max Revenue beat(4)5.68%
Revenue beat(8)3
Avg Revenue beat(8)-3.75%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)3
Avg Revenue beat(16)-6.48%
PT rev (1m)-8.33%
PT rev (3m)-9.59%
EPS NQ rev (1m)3.51%
EPS NQ rev (3m)-23.14%
EPS NY rev (1m)-66.54%
EPS NY rev (3m)-72.23%
Revenue NQ rev (1m)-2.55%
Revenue NQ rev (3m)-5.32%
Revenue NY rev (1m)-1.43%
Revenue NY rev (3m)-2.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.4
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)-6.7
EYN/A
EPS(NY)-1.43
Fwd EYN/A
FCF(TTM)-1.15
FCFYN/A
OCF(TTM)-1.01
OCFYN/A
SpS7.81
BVpS24.66
TBVpS23.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.04%
ROE -29.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.13%
FCFM N/A
ROA(3y)-13.01%
ROA(5y)-1.54%
ROE(3y)-15.27%
ROE(5y)-1.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.75%
GM growth 5Y3.28%
F-Score5
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.99%
Cap/Sales 1.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.78
Quick Ratio 2.78
Altman-Z 2
F-Score5
WACC8.22%
ROIC/WACCN/A
Cap/Depr(3y)55.99%
Cap/Depr(5y)58.5%
Cap/Sales(3y)1.82%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.83%
EPS Next Y3.73%
EPS Next 2Y30.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.07%
Revenue growth 3Y-15.21%
Revenue growth 5Y-15.81%
Sales Q2Q%-6.61%
Revenue Next Year-5.69%
Revenue Next 2Y-3.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.14%
OCF growth 3YN/A
OCF growth 5YN/A